Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 113.60
-3.20 (-2.74%)
Sep 11, 2026, 5:30 PM CET
Medacta Group Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 707.85 | 683.83 | 590.58 | 510.78 | 437.12 | 363.13 | |
Revenue Growth | 9.56% | 15.79% | 15.62% | 16.85% | 20.38% | 20.04% |
Cost of Revenue | 244.14 | 225.17 | 191.14 | 162.93 | 131.87 | 101.88 |
Gross Profit | 463.72 | 458.66 | 399.44 | 347.85 | 305.26 | 261.25 |
Selling, General & Admin | 332.87 | 321.07 | 284.54 | 252.47 | 220.22 | 182.39 |
Research & Development | 22.32 | 21.47 | 20.82 | 18.77 | 15.08 | 10.91 |
Other Operating Expenses | 1.02 | 1.3 | 0.67 | 0.09 | 0.51 | 0.87 |
Operating Expenses | 356.22 | 343.84 | 306.03 | 271.34 | 235.8 | 194.17 |
Operating Income | 107.5 | 114.83 | 93.41 | 76.51 | 69.46 | 67.08 |
Interest Expense | -5.75 | -6.81 | -7.51 | -6.83 | -3.66 | -3.44 |
Interest & Investment Income | 1.69 | 0.47 | 0.22 | 0.1 | 0.35 | 0.33 |
Currency Exchange Gain (Loss) | -5.95 | -5.95 | 7.53 | -10.46 | -2.98 | 1.03 |
Other Non Operating Income (Expenses) | 2.53 | 2.53 | -3.31 | 1.47 | -0.38 | -1.25 |
EBT Excluding Unusual Items | 100.02 | 105.07 | 90.34 | 60.79 | 62.79 | 63.76 |
Merger & Restructuring Charges | - | -1.38 | - | - | - | - |
Asset Writedown | -2.05 | -2.05 | -0.57 | -0.79 | -0.52 | -0.4 |
Legal Settlements | - | - | -2 | -0.52 | -6.85 | -7.91 |
Other Unusual Items | - | 13.65 | - | -0.75 | -0.63 | - |
Pretax Income | 97.97 | 115.29 | 87.77 | 58.73 | 54.79 | 55.45 |
Income Tax Expense | 20.69 | 19.83 | 14.88 | 11.36 | 8.54 | 3.93 |
Net Income | 77.28 | 95.46 | 72.89 | 47.36 | 46.25 | 51.52 |
Net Income to Common | 77.28 | 95.46 | 72.89 | 47.36 | 46.25 | 51.52 |
Net Income Growth | -18.59% | 30.97% | 53.89% | 2.41% | -10.23% | 38.90% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Change | 0.06% | 0.08% | -0.18% | -0.02% | -0.04% | 0.02% |
EPS (Basic) | 3.88 | 4.79 | 3.66 | 2.37 | 2.32 | 2.58 |
EPS (Diluted) | 3.87 | 4.78 | 3.65 | 2.37 | 2.31 | 2.58 |
EPS Growth | -18.68% | 30.96% | 54.01% | 2.60% | -10.34% | 39.27% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.77 | 29.71 | 17.88 | 5.47 | 15.11 | 7.57 |
Free Cash Flow Per Share | -0.09 | 1.49 | 0.90 | 0.27 | 0.76 | 0.38 |
Dividend Per Share | 1.181 | 1.181 | 0.735 | 0.591 | 0.546 | 0.516 |
Dividend Growth | 60.65% | 60.65% | 24.46% | 8.14% | 5.89% | - |
Gross Margin | 65.51% | 67.07% | 67.64% | 68.10% | 69.83% | 71.94% |
Operating Margin | 15.19% | 16.79% | 15.82% | 14.98% | 15.89% | 18.47% |
Profit Margin | 10.92% | 13.96% | 12.34% | 9.27% | 10.58% | 14.19% |
Free Cash Flow Margin | -0.25% | 4.34% | 3.03% | 1.07% | 3.46% | 2.08% |
EBITDA | 170.53 | 171.86 | 142.66 | 119.64 | 106.96 | 97.82 |
EBITDA Margin | 24.09% | 25.13% | 24.16% | 23.42% | 24.47% | 26.94% |
D&A For EBITDA | 63.03 | 57.04 | 49.25 | 43.13 | 37.5 | 30.73 |
EBIT | 107.5 | 114.83 | 93.41 | 76.51 | 69.46 | 67.08 |
EBIT Margin | 15.19% | 16.79% | 15.82% | 14.98% | 15.89% | 18.47% |
Effective Tax Rate | 21.12% | 17.20% | 16.96% | 19.35% | 15.59% | 7.09% |